Stockholm, Sweden, Jan. 23, 2012 - Attana has today released the events schedule for the first months of 2012. Participation is scheduled at exhibitions and conferences on three continents during February, March and April. The events include, amongst others, the Discovery Summit in Cannes and PEGS in Boston.
At the events Attana will present the latest product news and application development.
Attana has released a product note explaining the benefits of bridging the gap between traditional biochemical biosensors and cell based assays
Stockholm, Sweden, November 18, 2011 - Today, Attana released a product note explaining the benefits of bridging the gap between traditional biochemical biosensors and cell based assays.
Investing in global customer proximity is the new strategy for Swedish biosensor company Attana AB. Last week, the company announced an extended distribution agreement under which Tecan now will distribute Attana's label-free QCM biosensors in Europe as well.
Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe.
Attana and Layerlab announced today that they have signed a global distribution agreement under which Attana will distribute memLAYER™ for utilization together with Attana’s QCM biosensors. With biosensor users in mind, both Attana and Layerlab can now offer the market new and improved application methods.
Lonza Biologics and Attana have collaborated on an article in Innovations in Pharmaceutical Technology.
The combination of computational and protein engineering tools with novel orthogonal methods of measuring aggregation can be used to assess the developability of biopharm products in the early stages of development, thereby reducing the level of risk in later stages.
Attana AB, developer of biosensors, is proud to announce our particpation in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series.
We are gearing up for an exciting month of March with many interesting events. Just in the last two weeks of the month we will be showing the latest Attana systems at conferences in France, China, Switzerland and the US.
To ensure you don't miss out, please visit our Events section by clicking here.
Tecan and Attana now offering the biopharmaceutical society complete solutions within sample handling and systems for detection and full characterization for molecular interactions.
About us
Attana AB develops biosensors for the pharma, diagnostic and academic societies. By character- izing molecular interactions exactly as they occur in the human body, we provide the life science community with biologically relevant information.
